ScoreWhy is Medexus Pharmaceuticals, Inc. ?
1
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 95.27%, its profits have fallen by -108.3%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Medexus Pharmaceuticals, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Medexus Pharmaceuticals, Inc.
73.58%
1.92
45.15%
S&P/TSX 60
20.36%
2.51
12.02%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.37%
EBIT Growth (5y)
0.43%
EBIT to Interest (avg)
1.23
Debt to EBITDA (avg)
11.93
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.37
Tax Ratio
0.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
10.93%
ROE (avg)
4.69%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.88
EV to EBIT
35.24
EV to EBITDA
8.35
EV to Capital Employed
1.73
EV to Sales
1.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.92%
ROE (Latest)
-1.22%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
INTEREST COVERAGE RATIO(Q)
Highest at 999.34
RAW MATERIAL COST(Y)
Fallen by 0.51% (YoY
NET SALES(Q)
Highest at CAD 39.57 MM
OPERATING PROFIT(Q)
Highest at CAD 6.27 MM
PRE-TAX PROFIT(Q)
Highest at CAD 1.8 MM
NET PROFIT(Q)
Highest at CAD 1.86 MM
EPS(Q)
Highest at CAD 0.02
-5What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at CAD 17.22 MM
ROCE(HY)
Lowest at -4.61%
Here's what is working for Medexus Pharmaceuticals, Inc.
Interest Coverage Ratio
Highest at 999.34 and Grown
In each period in the last five periodsMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales
Highest at CAD 39.57 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CAD MM)
Operating Profit
Highest at CAD 6.27 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CAD MM)
Pre-Tax Profit
Highest at CAD 1.8 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD 1.86 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
EPS
Highest at CAD 0.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CAD)
Raw Material Cost
Fallen by 0.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Medexus Pharmaceuticals, Inc.
Operating Cash Flow
Lowest at CAD 17.22 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CAD MM)
Footer loading
